middle.news
How Will Recce’s New China Patent Transform Its Anti-Infective Ambitions?
1:40am on Monday 2nd of June, 2025 AEST
•
Pharmaceuticals
Read Story
How Will Recce’s New China Patent Transform Its Anti-Infective Ambitions?
1:40am on Monday 2nd of June, 2025 AEST
Key Points
China Intellectual Property Administration accepts new patent family for RECCE® anti-infectives
Patent covers RECCE® 327 and RECCE® 529 for multiple bacterial and viral infections
Includes diverse administration methods: oral, inhalation, injection, topical
China’s antibiotic market valued at over US$4 billion with 5.7% projected growth
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Recce Pharmaceuticals (ASX:RCE)
OPEN ARTICLE